| Test Name | Test Code | Specimen | Schedule | TAT | Division |
|---|---|---|---|---|---|
| PDGFR Alpha Gene Rearrangement; 4q12 | CG2068 | 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) | Daily | 8 days | Cytogenetics |
| PDGFR Beta Gene Rearrangement; 5q33 | CG2069 | 5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) | Daily | 8 days | Cytogenetics |
| Phenytoin Genetic Test | MG3041 | 5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) | Daily | 10 days | Molecular Genetics |
| PAI-1 Mutation Analysis (4G/5G allele) | MG3059 | 5ml Blood in K2/K3 EDTA Tube (LCT) | Daily | 7 days | Molecular Genetics |
| PDGFRA Target Exons Sequence Analysis | MG3060 | Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] | Daily | 10 days | Molecular Genetics |
| PIK3CA Target Mutation Analysis | MG3061 | Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] | Daily | 7 days | Molecular Genetics |
| Platinum Drug Response Genetic Test (GSTP1, XRCC1, ERCC2) | MG3062 | 5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) | Daily | 7 days | Molecular Genetics |
| Prothrombin Mutation Analysis (G20210A) | MG3063 | 5ml Blood in K2/K3 EDTA Tube (LCT) | Daily | 7 days | Molecular Genetics |
| Praderwilli Syndrome Methylation PCR | MG3122 | 5ml Blood in K2/K3 EDTA Tube (LCT) | Fri | 15 days | Molecular Genetics |
| PDGFRA Target Exon Sequence Analysis | MG3127 | 5 ml Blood or 3 ml Bone marrow in EDTA Vacut. (PCT) or FFPE or Tumor Tissue or FNA | Daily | 7 days | Molecular Genetics |
